Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 4Uveal Melanoma 2Neoplasms 2Neoplasm Metastasis 1Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

Ipilimumab 12tremelimumab 6durvalumab 6Nivolumab 6pembrolizumab 4Paclitaxel 2Oxaliplatin 2Carboplatin 2Capecitabine 2Blood Specimen Collection 2spartalizumab 1relatlimab 1lenvatinib 1folfirinox 1Vaccines 1Radiotherapy 1Radiofrequency Ablation 1Radiation 1Opdualag 1Monophenol Monooxygenase 1Leucovorin 1Fluorouracil 1Docetaxel 1Cryosurgery 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Insulin-Dependent, 12 × Monophenol Monooxygenase × Clear all
NCT00028431 2014-05-22

Novel Adjuvants for Peptide-Based Melanoma Vaccines

University of Southern California

Phase 1 Completed
19 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡